Figure 5. Exosomal miR-222 secreted by gWAT inhibits the sensitivity of the insulin signal pathway by repressing IRS1. (A) Representative diagram shows the results of TargetScan (http://www.targetscan.org/vert_72/) analysis predicting the presence of the miR-222 target site in the 3'-UTR of IRS-1. (B) QRT-PCR analysis shows the relative expression of miR-222 in the miR-NC- and miR-222 mimic-transfected Hepa 1-6 cells for 48 h (n=5 per group). (C) Western blot analysis shows IRS1 protein levels in the Hepa 1-6 cells transfected with miR-NC- and miR-222 mimic for 48 h. β-actin was used as loading control. (D) Western blot analysis shows phospho-AKT and AKT protein levels in the Hepa 1-6 cells transfected with miR-NC- and miR-222 mimic for 48 h and further treated with (+) or without (-)100 nM insulin for 10 min. The phospho-AKT levels were normalized to the total AKT levels. (E) Luciferase reporter activity assay results show the normalized luciferase activity in the HEK-293T cells co-transfected with miR-NC or miR-222 mimic plus pMIR-IRS1-WT plasmid or pMIR-IRS1-MUT plasmid (n=3 per group). (F) QRT-PCR analysis shows the relative expression of miR-222 in the Hepa 1-6 cells co-cultured with CD-gWAT-Exos or HFD-gWAT-Exos for 48h (n=5 per group). (G) Western blot analysis shows IRS1 protein levels in the Hepa 1-6 cells co-cultured with CD-gWAT-Exos or HFD-gWAT-Exos relative to the mock control at 48h. β-actin was used as loading control. The analysis is based on